Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 64,872 | 49,647 | 16,100 | 16,778 | 19,357 |
| Cost of Goods | 15,975 | 6,335 | 2,738 | 2,637 | 4,186 |
| Gross Profit | 48,897 | 43,312 | 13,362 | 14,141 | 15,171 |
| Operating Expenses | 205,413 | 194,852 | 144,320 | 92,406 | 105,610 |
| Operating Income | -155,541 | -151,205 | -130,220 | -77,629 | -90,254 |
| Interest Expense | 28,581 | 17,382 | 4,678 | 0 | 0 |
| Other Income | 598 | -7,558 | 2,281 | 703 | 378 |
| Pre-tax Income | -183,524 | -176,145 | -132,617 | -76,925 | -89,876 |
| Net Income Continuous | -183,524 | -176,145 | -132,617 | -76,925 | -89,876 |
| Net Income | $-183,524 | $-176,145 | $-132,617 | $-76,925 | $-89,876 |
| EPS Basic Total Ops | -33.50 | -36.00 | -29.50 | -18.50 | -23.00 |
| EPS Basic Continuous Ops | -33.29 | -35.75 | -29.47 | -18.71 | -22.92 |
| EPS Diluted Total Ops | -33.50 | -36.00 | -29.50 | -18.50 | -23.00 |
| EPS Diluted Continuous Ops | -33.29 | -35.75 | -29.47 | -18.71 | -22.92 |
| EPS Diluted Before Non-Recurring Items | -34.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-151,474 | $-149,813 | $-129,656 | $-77,416 | $-90,121 |